Total Payments
$6,043
2024 Payments
$566.07
Companies
47
Transactions
288
Medicare Patients
1,743
Medicare Billing
$107,071
Payment Breakdown by Category
Food & Beverage$5,930 (98.1%)
Education$113.23 (1.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,930 | 280 | 98.1% |
| Education | $113.23 | 8 | 1.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,227 | 56 | $0 (2024) |
| Novo Nordisk Inc | $722.73 | 30 | $0 (2024) |
| PFIZER INC. | $498.40 | 33 | $0 (2023) |
| Daiichi Sankyo Inc. | $454.93 | 22 | $0 (2023) |
| Amgen Inc. | $324.20 | 8 | $0 (2022) |
| Astellas Pharma US Inc | $206.62 | 8 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $205.26 | 11 | $0 (2024) |
| AMAG Pharmaceuticals, Inc. | $186.68 | 8 | $0 (2019) |
| CooperSurgical, Inc. | $157.92 | 9 | $0 (2024) |
| TherapeuticsMD, Inc. | $150.28 | 9 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $566.07 | 14 | Novo Nordisk Inc ($153.33) |
| 2023 | $1,233 | 54 | Novo Nordisk Inc ($224.32) |
| 2022 | $1,203 | 54 | ABBVIE INC. ($390.84) |
| 2021 | $702.18 | 37 | AbbVie Inc. ($137.33) |
| 2020 | $479.78 | 25 | Novo Nordisk Inc ($170.98) |
| 2019 | $750.73 | 38 | AbbVie, Inc. ($224.91) |
| 2018 | $596.01 | 33 | AbbVie, Inc. ($165.19) |
| 2017 | $512.12 | 33 | PFIZER INC. ($165.12) |
All Payment Transactions
288 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/07/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $27.21 | General |
| Category: HORMONE THERAPY | ||||||
| 10/31/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: UROLOGY | ||||||
| 10/24/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Biological | ||||||
| 09/03/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $23.82 | General |
| Category: UROLOGY | ||||||
| 08/27/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kyleena (Drug), Mirena, Skyla | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: Womens Health | ||||||
| 08/21/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $107.95 | General |
| Category: Obesity | ||||||
| 08/13/2024 | Organon Llc | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: ETONOGESTREL | ||||||
| 06/14/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: Obesity | ||||||
| 06/11/2024 | CooperSurgical, Inc. | Paragard T 380A (Drug) | Food and Beverage | In-kind items and services | $21.66 | General |
| Category: Endocrinology | ||||||
| 04/24/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: Obesity | ||||||
| 03/19/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $25.62 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 02/28/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | Cash or cash equivalent | $121.72 | General |
| Category: Obesity | ||||||
| 02/08/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: Obesity | ||||||
| 01/03/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: Obesity | ||||||
| 12/11/2023 | Myriad Women's Health, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $110.54 | General |
| Category: ONCOLOGY | ||||||
| 12/07/2023 | Evofem Biosciences, Inc. | Phexxi (Drug) | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: Miscellaneous vaginal agent | ||||||
| 11/29/2023 | AbbVie Inc. | LO LOESTRIN FE (Drug), ORILISSA | Food and Beverage | In-kind items and services | $20.85 | General |
| Category: WOMENS HEALTH | ||||||
| 11/02/2023 | CooperSurgical, Inc. | PARAGARD T 380A (Drug) | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: Endocrinology | ||||||
| 10/17/2023 | AbbVie Inc. | LILETTA (Drug) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: WOMENS HEALTH | ||||||
| 08/30/2023 | Evofem Biosciences, Inc. | Phexxi (Drug) | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: Miscellaneous vaginal agent | ||||||
| 08/23/2023 | AbbVie Inc. | LO LOESTRIN FE (Drug), ORILISSA | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: WOMENS HEALTH | ||||||
| 08/22/2023 | CooperSurgical, Inc. | PARAGARD T 380A (Drug) | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: Endocrinology | ||||||
| 08/16/2023 | Agile Therapeutics, Inc. | Twirla (Drug) | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: Birth Control Contraceptive Patch | ||||||
| 08/07/2023 | AbbVie Inc. | LILETTA (Drug) | Food and Beverage | In-kind items and services | $20.35 | General |
| Category: WOMENS HEALTH | ||||||
| 08/02/2023 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $20.26 | General |
| Category: HORMONE THERAPY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 77 | 93 | $22,522 | $7,043 |
| 2022 | 11 | 399 | 448 | $83,626 | $21,889 |
| 2021 | 12 | 627 | 758 | $136,460 | $38,210 |
| 2020 | 11 | 640 | 808 | $153,963 | $39,929 |
Total Patients
1,743
Total Services
2,107
Medicare Billing
$107,071
Procedure Codes
38
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 36 | 47 | $8,283 | $3,075 | 37.1% |
| 76830 | Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | Office | 2023 | 16 | 21 | $7,875 | $1,840 | 23.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $5,484 | $1,715 | 31.3% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 11 | 11 | $880.00 | $412.50 | 46.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 121 | 159 | $23,316 | $8,215 | 35.2% |
| 77067 | Screening mammography | Office | 2022 | 54 | 54 | $20,412 | $4,803 | 23.5% |
| 76830 | Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | Office | 2022 | 30 | 37 | $15,349 | $2,947 | 19.2% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 39 | 39 | $3,306 | $1,500 | 45.4% |
| 77063 | Screening 3d breast mammography | Office | 2022 | 55 | 55 | $5,225 | $1,242 | 23.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 16 | 16 | $3,800 | $1,221 | 32.1% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2022 | 26 | 26 | $8,346 | $942.60 | 11.3% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2022 | 14 | 14 | $1,386 | $588.56 | 42.5% |
| 76376 | 3d radiographic procedure | Office | 2022 | 13 | 16 | $1,720 | $283.87 | 16.5% |
| 87210 | Smear for infectious agents | Office | 2022 | 18 | 18 | $486.00 | $104.10 | 21.4% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2022 | 13 | 14 | $280.00 | $41.44 | 14.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 164 | 262 | $36,746 | $15,922 | 43.3% |
| 77067 | Screening mammography of both breasts | Office | 2021 | 127 | 127 | $48,006 | $10,993 | 22.9% |
| 76830 | Ultrasound pelvis through vagina | Office | 2021 | 29 | 40 | $17,680 | $3,235 | 18.3% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 60 | 60 | $5,160 | $2,309 | 44.7% |
| 77080 | Bone density measurement of the core or central skeleton (e.g., hips, pelvis, spine) | Office | 2021 | 52 | 52 | $14,193 | $1,723 | 12.1% |
| 77063 | Screening digital tomography of both breasts | Office | 2021 | 71 | 71 | $6,745 | $1,684 | 25.0% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 15 | 15 | $3,127 | $938.93 | 30.0% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2021 | 22 | 22 | $2,178 | $930.82 | 42.7% |
| 87210 | Smear for infectious agents | Office | 2021 | 24 | 28 | $756.00 | $162.96 | 21.6% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2021 | 28 | 40 | $800.00 | $126.80 | 15.9% |
About Dr. William Terry, MD
Dr. William Terry, MD is a Specialist healthcare provider based in Pinehurst, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1639159155.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Terry, MD has received a total of $6,043 in payments from pharmaceutical and medical device companies, with $566.07 received in 2024. These payments were reported across 288 transactions from 47 companies. The most common payment nature is "Food and Beverage" ($5,930).
As a Medicare-enrolled provider, Terry has provided services to 1,743 Medicare beneficiaries, totaling 2,107 services with total Medicare billing of $107,071. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location Pinehurst, NC
- Active Since 01/19/2006
- Last Updated 09/06/2018
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1639159155
Products in Payments
- INJECTAFER (Drug) $454.93
- Saxenda (Drug) $364.83
- Wegovy (Drug) $323.27
- PREMARIN (Drug) $303.11
- Orilissa (Drug) $287.14
- MYFEMBREE (Drug) $264.16
- EVENITY (Biological) $245.96
- ORIAHNN (Drug) $239.49
- LILETTA (Drug) $233.48
- LO LOESTRIN FE (Drug) $172.69
- ORILISSA (Drug) $165.98
- INTRAROSA (Drug) $145.91
- ZEPBOUND (Drug) $141.37
- GEMTESA (Drug) $129.82
- Veozah (Drug) $124.99
- PREMARIN ORALS (Drug) $113.55
- Balcoltra (Drug) $111.41
- MYRISK (Device) $110.54
- Phexxi (Drug) $107.52
- Axonics r-SNM System (Device) $105.54
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Pinehurst
Heidi Swygard, M.d, M.D
Specialist — Payments: $23,073
Specialist $23,073
Henry Tellez, M.d, M.D
Specialist — Payments: $1,166
Specialist $1,166
Giridhar Chintalapudi, M.d, M.D
Specialist — Payments: $1,095
Specialist $1,095
Mark Medford, M.d, M.D
Specialist — Payments: $838.26
Specialist $838.26
Lourdes Castano, Md, MD
Specialist — Payments: $666.84
Specialist $666.84
Mr. Daniel Difrischia, M.d, M.D
Specialist — Payments: $341.35
Specialist $341.35